Richard W. Paul & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1K | Hold |
4
| – | – | ﹤0.01% | 299 |
|
|
2025
Q1 | $2.54K | Hold |
4
| – | – | ﹤0.01% | 277 |
|
|
2024
Q4 | $2.85K | Hold |
4
| – | – | ﹤0.01% | 395 |
|
|
2024
Q3 | $4.21K | Hold |
4
| – | – | ﹤0.01% | 356 |
|
|
2024
Q2 | $4.2K | Hold |
4
| – | – | ﹤0.01% | 353 |
|
|
2024
Q1 | $3.85K | Hold |
4
| – | – | ﹤0.01% | 375 |
|
|
2023
Q4 | $3.51K | Hold |
4
| – | – | ﹤0.01% | 373 |
|
|
2023
Q3 | $3.29K | Sell |
4
-3
| -43% | -$2.47K | ﹤0.01% | 368 |
|
|
2023
Q2 | $5.03K | Hold |
7
| – | – | ﹤0.01% | 363 |
|
|
2023
Q1 | $5.75K | Hold |
7
| – | – | ﹤0.01% | 365 |
|
|
2022
Q4 | $5.05K | Buy |
+7
| New | +$5.05K | ﹤0.01% | 369 |
|